Biodesix, Inc. (BDSX)
NASDAQ: BDSX · IEX Real-Time Price · USD
1.575
+0.015 (0.96%)
At close: May 17, 2024, 4:00 PM
1.650
+0.075 (4.76%)
After-hours: May 17, 2024, 5:21 PM EDT

Biodesix Revenue

Biodesix had revenue of $54.85M in the twelve months ending March 31, 2024, with 34.70% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $14.82M with 63.63% year-over-year growth. In the year 2023, Biodesix had annual revenue of $49.09M with 28.46% growth.

Revenue (ttm)
$54.85M
Revenue Growth
+34.70%
P/S Ratio
3.28
Revenue / Employee
$252,760
Employees
217
Market Cap
180.06M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202349.09M10.88M28.46%
Dec 31, 202238.21M-16.29M-29.89%
Dec 31, 202154.51M8.95M19.64%
Dec 31, 202045.56M21.01M85.55%
Dec 31, 201924.55M4.12M20.16%
Dec 31, 201820.43M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Lifecore Biomedical 103.27M
OptiNose 74.02M
CVRx, Inc. 42.09M
Stereotaxis 27.10M
Abeona Therapeutics 3.50M
Orchestra BioMed Holdings 2.22M
Revenue Rankings